Trial Profile
Phase II Study of Acolbifene in Pre-Menopausal Women at High Risk for Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Acolbifene (Primary)
- Indications Breast cancer; Ductal carcinoma
- Focus Biomarker; Therapeutic Use
- 06 Feb 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.